Male pattern baldness linked to BPH symptoms

Article

Spanish researchers have found that early-onset androgenetic alopecia (AGA) may be a marker of urinary symptoms associated with BPH.

Spanish researchers have found that early-onset androgenetic alopecia (AGA) may be a marker of urinary symptoms associated with BPH.

Researchers at San Cecilio University in Granada conducted an observational case-control study of 45 men with early-onset AGA (mean age, 52.7 years) and 42 control subjects (mean age, 49.8 years). Prostatic volume and urinary flow were both measured, a hormone study was performed on all participants, and the International Prostate Symptom Score and International Index of Erectile Function score were assessed.

The authors found that patients with AGA had significantly higher mean prostate volume, International Prostate Symptom Score, and PSA levels. Patients with AGA also had significantly lower maximum urinary flow compared with controls. There was also a strong association between the presence of AGA and BPH after adjusting for a number of variables.

"There is a relationship between the presence of AGA and prostate-growth-associated urinary symptoms, likely attributable to their pathophysiological similarity," the authors wrote in the Journal of the American Academy of Dermatology (2012; 66:401-8). "This study suggests that early-onset AGA may be an early marker of urinary/prostatic symptomatology. Future studies may clarify whether treatment of patients with AGA may benefit the concomitant benign prostatic hypertrophy, which would be present at an earlier stage in its natural evolution."

Go back to this issue of Urology Times eNews.

Related Content

BPH scores improved by PDE-5 inhibitor, alpha-blocker

Study: Functional outcomes better with HoLEP vs. PVP

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.